Cargando…

Rare Heterogeneous Adverse Events Associated with mRNA-Based COVID-19 Vaccines: A Systematic Review

Background: Since the successful development, approval, and administration of vaccines against SARS-CoV-2, the causative agent of COVID-19, there have been reports in the published literature, passive surveillance systems, and other pharmacovigilance platforms of a broad spectrum of adverse events f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oueijan, Rana I., Hill, Olivia R., Ahiawodzi, Peter D., Fasinu, Pius S., Thompson, Dorothea K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9416135/ https://www.ncbi.nlm.nih.gov/pubmed/36005648 http://dx.doi.org/10.3390/medicines9080043

Ejemplares similares

Sexually Transmitted Neisseria gonorrhoeae Infections—Update on Drug Treatment and Vaccine Development
por: Jefferson, Amber, et al.
Publicado: (2021)

mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation
por: Fenton, Caroline, et al.
Publicado: (2022)

COVID-19 mRNA Vaccines: The Molecular Basis of Some Adverse Events
por: Giannotta, Girolamo, et al.
Publicado: (2023)

Clinical Management of COVID-19: A Review of Pharmacological Treatment Options
por: Heustess, Ashli M., et al.
Publicado: (2021)

Safety and Adverse Events Related to COVID-19 mRNA Vaccines; a Systematic Review
por: SeyedAlinaghi, SeyedAhmad, et al.
Publicado: (2022)

Early Adverse Events between mRNA and Adenovirus-Vectored COVID-19 Vaccines in Healthcare Workers
por: Wi, Yu-Mi, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination in Lactation: Assessment of adverse events and vaccine related antibodies in mother-infant dyads
por: Golan, Yarden, et al.
Publicado: (2021)

COVID-19 mRNA Vaccination in Lactation: Assessment of Adverse Events and Vaccine Related Antibodies in Mother-Infant Dyads
por: Golan, Yarden, et al.
Publicado: (2021)

Serious adverse events of special interest following mRNA COVID-19 vaccination in randomized trials in adults
por: Fraiman, Joseph, et al.
Publicado: (2022)

Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
por: Gronbeck, Christian, et al.
Publicado: (2021)

Propensity-Score-Matched Evaluation of Adverse Events Affecting Recovery after COVID-19 Vaccination: On Adenovirus and mRNA Vaccines
por: Son, Chang-Sik, et al.
Publicado: (2022)

Heterogeneous Longitudinal Antibody Responses to Covid-19 mRNA Vaccination
por: de la Monte, Suzanne M, et al.
Publicado: (2021)

Adverse reactions to the BNT162b2 and mRNA-1273 mRNA COVID-19 vaccines in Japan
por: Kitagawa, Hiroki, et al.
Publicado: (2022)

Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
por: Trougakos, Ioannis P., et al.
Publicado: (2022)

Methotrexate adversely affects immunogenicity to COVID-19 mRNA vaccines
Publicado: (2021)

Adverse events following mRNA SARS-CoV-2 vaccination among U.S. nursing home residents
por: Bardenheier, Barbara H., et al.
Publicado: (2021)

COVID-19 mRNA vaccines and immune-related adverse events in cancer patients treated with immune checkpoint inhibitors
por: Chen, Yu-Wei, et al.
Publicado: (2021)

Reports of acute adverse events in mRNA COVID-19 vaccine recipients after the first and second doses in Japan
por: Akaishi, Tetsuya, et al.
Publicado: (2022)

Adverse events following COVID‐19 mRNA vaccines: A systematic review of cardiovascular complication, thrombosis, and thrombocytopenia
por: Yasmin, Farah, et al.
Publicado: (2023)

Myocardial infarction or myocarditis? A case report and review of a myocardial adverse event associated with mRNA vaccine
por: Badaró, Roberto, et al.
Publicado: (2023)

Comparative Risks of Potential Adverse Events Following COVID-19 mRNA Vaccination Among Older US Adults
por: Harris, Daniel A., et al.
Publicado: (2023)

1669. Antimicrobial Resistance Patterns of Uropathogenic Escherichia coli: Comparison of Infection Setting and Community Classification
por: Muradyan, Adriana, et al.
Publicado: (2020)

Myocarditis rare after COVID-19 mRNA vaccination
Publicado: (2021)

mRNA as a Therapeutics: Understanding mRNA Vaccines
por: Oğuz, Ferdi, et al.
Publicado: (2022)

mRNA Vaccine Platform: mRNA Production and Delivery
por: Litvinova, V. R., et al.
Publicado: (2023)

Rare Adverse Events Associated with BNT162b2 mRNA Vaccine (Pfizer-BioNTech): A Review of Large-Scale, Controlled Surveillance Studies
por: Yong, Shin-Jie, et al.
Publicado: (2022)

No adverse effects found for prenatal exposure to mRNA COVID-19 vaccine
Publicado: (2022)

COVID-19 mRNA vaccine-induced adverse effects: unwinding the unknowns
por: Trougakos, Ioannis P., et al.
Publicado: (2022)

Adverse events after mRNA vaccine administration from a busy orthopedic practice: a series of four cases
por: Elkousy, Hussein A., et al.
Publicado: (2022)

Adverse Events and Immunogenicity of mRNA-Based COVID-19 Vaccine among Healthcare Workers: A Single-Centre Experience
por: Sauserienė, Jolanta, et al.
Publicado: (2022)

Short term adverse event profile of COVID-19 mRNA vaccines in children aged 5–15 years in Australia
por: Wood, Nicholas, et al.
Publicado: (2023)

COVID-19 mRNA vaccination is associated with IgA nephropathy: an analysis of the Japanese adverse drug event report database
por: Nakao, Hiroka, et al.
Publicado: (2023)

Adverse Events Following mRNA COVID-19 Vaccine in 2021 and 2022: A Retrospective Analysis in Costa Rica and Italy
por: Serrano-Arias, Bruno, et al.
Publicado: (2023)

Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)
por: Welsh, Kerry J., et al.
Publicado: (2021)

Pitolisant and Other Histamine-3 Receptor Antagonists—An Update on Therapeutic Potentials and Clinical Prospects
por: Harwell, Victoria, et al.
Publicado: (2020)

Vaccination-associated cardiac adverse events rare
Publicado: (2022)

Correlation between Adverse Events and Antibody Titers among Healthcare Workers Vaccinated with BNT162b2 mRNA COVID-19 Vaccine
por: Levy, Itzchak, et al.
Publicado: (2022)

Risks of Myocarditis and Pericarditis Following Vaccination with SARS-CoV-2 mRNA Vaccines in Japan: An Analysis of Spontaneous Reports of Suspected Adverse Events
por: Kobayashi, Hidetaka, et al.
Publicado: (2022)

Adverse Reaction to COVID-19 mRNA Vaccination in a Patient With VEXAS Syndrome
por: Ciprian, Giulio
Publicado: (2022)

Dangers of mRNA vaccines
por: Ali, Tahoora, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_tar8clsi5vfbel13at1lbn8plj